112 related articles for article (PubMed ID: 19417909)
1. An impedimetric microelectrode-based array sensor for label-free detection of tau hyperphosphorylation in human cells.
Jahnke HG; Rothermel A; Sternberger I; Mack TG; Kurz RG; Pänke O; Striggow F; Robitzki AA
Lab Chip; 2009 May; 9(10):1422-8. PubMed ID: 19417909
[TBL] [Abstract][Full Text] [Related]
2. A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring.
Krinke D; Jahnke HG; Mack TG; Hirche A; Striggow F; Robitzki AA
Biosens Bioelectron; 2010 Sep; 26(1):162-8. PubMed ID: 20591644
[TBL] [Abstract][Full Text] [Related]
3. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease.
Alvarez-de-la-Rosa M; Silva I; Nilsen J; Pérez MM; García-Segura LM; Avila J; Naftolin F
Ann N Y Acad Sci; 2005 Jun; 1052():210-24. PubMed ID: 16024764
[TBL] [Abstract][Full Text] [Related]
4. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
[TBL] [Abstract][Full Text] [Related]
5. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
Wu X; Kosaraju J; Tam KY
Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
[TBL] [Abstract][Full Text] [Related]
6. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
[TBL] [Abstract][Full Text] [Related]
7. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
[TBL] [Abstract][Full Text] [Related]
8. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.
Ojala JO; Sutinen EM; Salminen A; Pirttilä T
J Neuroimmunol; 2008 Dec; 205(1-2):86-93. PubMed ID: 18947885
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice.
Uno Y; Iwashita H; Tsukamoto T; Uchiyama N; Kawamoto T; Kori M; Nakanishi A
Brain Res; 2009 Nov; 1296():148-63. PubMed ID: 19698704
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of Tat PTD-Hsp27 Fusion Protein on Tau Hyperphosphorylation Induced by Okadaic Acid in the Human Neuroblastoma Cell Line SH-SY5Y.
Choi S; Oh JH; Kim H; Nam SH; Shin J; Park JS
Cell Mol Neurobiol; 2015 Oct; 35(7):1049-59. PubMed ID: 25990227
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252a.
Hübinger G; Geis S; LeCorre S; Mühlbacher S; Gordon S; Fracasso RP; Hoffman F; Ferrand S; Klafki HW; Roder HM
J Alzheimers Dis; 2008 Apr; 13(3):281-94. PubMed ID: 18430996
[TBL] [Abstract][Full Text] [Related]
13. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
[TBL] [Abstract][Full Text] [Related]
14. Indirubin-3'-monoxime inhibits beta-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells.
Zhang S; Zhang Y; Xu L; Lin X; Lu J; Di Q; Shi J; Xu J
Neurosci Lett; 2009 Jan; 450(2):142-6. PubMed ID: 19027827
[TBL] [Abstract][Full Text] [Related]
15. Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells.
Zhou F; Chen S; Xiong J; Li Y; Qu L
Biol Trace Elem Res; 2012 Nov; 149(2):273-9. PubMed ID: 22528780
[TBL] [Abstract][Full Text] [Related]
16. A microelectrode-based sensor for label-free in vitro detection of ischemic effects on cardiomyocytes.
Krinke D; Jahnke HG; Pänke O; Robitzki AA
Biosens Bioelectron; 2009 May; 24(9):2798-803. PubMed ID: 19285854
[TBL] [Abstract][Full Text] [Related]
17. Effects of tau phosphorylation on proteasome activity.
Ren QG; Liao XM; Chen XQ; Liu GP; Wang JZ
FEBS Lett; 2007 Apr; 581(7):1521-8. PubMed ID: 17376439
[TBL] [Abstract][Full Text] [Related]
18. Impedance spectroscopy based measurement system for quantitative and label-free real-time monitoring of tauopathy in hippocampal slice cultures.
Jahnke HG; Braesigk A; Mack TG; Pönick S; Striggow F; Robitzki AA
Biosens Bioelectron; 2012 Feb; 32(1):250-8. PubMed ID: 22221799
[TBL] [Abstract][Full Text] [Related]
19. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
[TBL] [Abstract][Full Text] [Related]
20. Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast.
Vandebroek T; Vanhelmont T; Terwel D; Borghgraef P; Lemaire K; Snauwaert J; Wera S; Van Leuven F; Winderickx J
Biochemistry; 2005 Aug; 44(34):11466-75. PubMed ID: 16114883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
